PPARG and plasma cell myeloma: Wang et al. [211] showed that myeloma cells express PPARγ and that the PPARγ agonists, 15d-PGJ2 and troglitazone, abolish IL-6-inducible myeloma cell proliferation and promote apoptosis in a PPARγ-dependent manner.